...
首页> 外文期刊>Cytokine >IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor-1 and tissue-type plasminogen activator in cultured endothelial cells.
【24h】

IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor-1 and tissue-type plasminogen activator in cultured endothelial cells.

机译:IL-8会在培养的内皮细胞中诱导一氧化氮和内皮素-1之间以及纤溶酶原激活物抑制剂-1和组织型纤溶酶原激活物之间的失衡。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Interleukin-8 (IL-8), a member of the CXC chemokine family, plays an important role in the modulation of multiple biological functions in endothelial cells containing the receptors CXCR1 and CXCR2. It has previously been shown that IL-8 directly enhances endothelial cell survival, and stimulates the production of matrix metalloproteinases, which in turn regulates angiogenesis. However, its role in the regulation of the production of vasoactive substances in endothelial cells is less well defined. In this study, we investigate the effects of IL-8 on the proliferation of human umbilical vein endothelial cells (HUVECs). In addition, we also study the effects of IL-8 on the production of vasodilator, vasoconstrictor and fibrinolytic factors in these cells. The results show that recombinant IL-8 (50-200ng/ml) induces neither HUVEC proliferation nor nitric oxide (NO) release. However, it significantly increases the production of endothelin-1 (ET-1) in a concentration-dependent manner. Furthermore, incubationof endothelial cells with IL-8 (200ng/ml) up-regulates the plasminogen activator inhibitor-1 (PAI-1) in HUVECs, while it down-regulates the tissue plasminogen activator (t-PA). These findings suggest that IL-8 offsets the balance between endothelial vasoconstrictors and vasodilators. Furthermore, IL-8 also leads to an imbalance between PAI-1 and t-PA, which causes the ECs to become procoagulative and hypofibrinolytic.
机译:白细胞介素8(IL-8),CXC趋化因子家族的成员,在包含受体CXCR1和CXCR2的内皮细胞的多种生物学功能的调节中起重要作用。先前已经证明,IL-8直接提高内皮细胞的存活,并刺激基质金属蛋白酶的产生,进而调节血管生成。然而,其在调节内皮细胞中血管活性物质的产生中的作用尚不清楚。在这项研究中,我们研究了IL-8对人脐静脉内皮细胞(HUVEC)增殖的影响。此外,我们还研究了IL-8对这些细胞中血管扩张剂,血管收缩剂和纤溶因子产生的影响。结果表明重组IL-8(50-200ng / ml)既不诱导HUVEC增殖也不诱导一氧化氮(NO)释放。但是,它以浓度依赖性方式显着增加了内皮素-1(ET-1)的产生。此外,内皮细胞与IL-8(200ng / ml)的孵育可上调HUVEC中的纤溶酶原激活物抑制剂-1(PAI-1),而下调组织纤溶酶原激活物(t-PA)。这些发现表明IL-8抵消了内皮血管收缩剂和血管扩张剂之间的平衡。此外,IL-8还导致PAI-1和t-PA之间的失衡,这导致EC变得促凝和纤溶减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号